| About ResearchNet | Français |
|
|
| Home | FAQ | Contact Us | Sign-In |
| Search Again | Print Preview | Notify a Colleague |
| Funding Opportunity Details | ||||||||||
|
Important Dates | ||||||||||
|
Table of Contents
Description
Priority Announcements on CIHR Operating Grant competitions offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas or mandates. Applications are submitted through the March 2009 "2009(03)" competition of the Operating Grant: 2008-2009 funding opportunity. The Operating Grant Program is the foundation of CIHR's programming. CIHR recognizes that the creativity, skill, and insight of individuals and self-assembled teams lie at the heart of the research enterprise. The pursuit of excellence in research, as evaluated through the peer review process, inspires ideas that drive progress and ensures a continuous flow of fresh insights. Funds Available CIHR's contribution to the amount available for these strategic initiatives is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them. Funds Available for Research in All Areas: Funds are available for applications in all areas of research that address any important health problem or issue through the March 2009 "2009(03)" competition of the CIHR Operating Grant: 2008-2009 funding opportunity. Funds Available for Research in Specific Areas: In this competition, funds are available to encourage and support applications in specific areas that are aligned with CIHR's research priority areas and mandates. Information on the research areas to be funded and financial information are found in the "Objectives" section. A. CIHR Research Priority Areas:
B. Research Related to CIHR Institute Mandates:
Top Objectives
The specific objective of the Operating Grant Priority Announcement (Specific Research Areas) is to offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas and mandates. A. CIHR Research Priority Areas: 1. Aboriginal Health. The CIHR Institute of Aboriginal Peoples' Health (CIHR-IAPH) will fund applications that are determined to be relevant to the research priority areas described below:
The purpose of this Priority Announcement is to support scientifically excellent and relevant research that is focussed on investigating factors that can improve the health and well being of First Nations, Inuit and Métis people. CIHR-Institute of Aboriginal Peoples' Health (CIHR-IAPH) will support research relevant to its mandate across CIHR's four pillars: biomedical; clinical; health services and policy; and population and public health that will contribute to improving the health of Aboriginal peoples in Canada. CIHR-IAPH supports health research that addresses the special health needs of Aboriginal peoples in Canada, and aims to improve the health of First Nations, Inuit and Métis peoples through the assertion of Aboriginal understandings of health and by fostering innovative community-based and scientifically excellent research. More information on the research priorities of CIHR-IAPH can be found on their website. The total amount available for this initiative is $400,000. This amount may increase if additional funding partners decide to participate. CIHR-IAPH may fund two grants up to $100,000 each for two years. Additional Information:
For questions about this initiative and research objectives contact: Jacques Dalton For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 2. Blood Supply Risk. The CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH) in partnership with Canadian Blood Services (CBS) will fund applications that are determined to be relevant to the research priority areas described below:
The maximum amount awarded for a single grant is up to $100,000 per annum for up to 3 years. CBS has committed up to $1.0M over three years for this initiative through CIHR peer review. The total number and amount of grants to be funded will be determined by CBS following peer review evaluation. More information on the research priorities of CIHR-ICRH and Canadian Blood Services can be found on their websites. Additional Information:
For questions about this initiative and research objectives contact: For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 3. Blood Utilization. The CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH), in partnership with Canadian Blood Services (CBS), will fund applications that are determined to be relevant to the research priority area described below:
Blood products and their derivatives include cellular blood components (red blood cells and platelets), plasma products, therapeutic proteins fractionated from plasma, and replacement products for any of these including both recombinant proteins and synthetic materials. Conservation refers to strategies to reduce the use of donor-derived blood products. The maximum amount awarded for a single grant is up to $100,000 per annum for up to three years. CBS has committed up to $1.0M over three years for this initiative through CIHR peer review. The total number and amount of grants to be funded will be determined by CBS following peer review evaluation. More information on the research priorities of CIHR-ICRH and Canadian Blood Services can be found on their websites. Additional Information:
For questions about this initiative and research objectives contact: For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 4. Breast Cancer. CIHR, in partnership with the Canadian Breast Cancer Research Alliance (CBCRA) (1) will fund applications that are determined to be relevant to the research priority area described below:
It is the objective of the Alliance to fund a broad spectrum of cancer research in Canada that will have relevance for prevention, early detection, diagnosis, treatment, rehabilitation and palliation for people impacted by breast cancer. Such research could encompass, but is not limited to, fundamental laboratory investigations, clinical trials and epidemiological, psychosocial and behavioural studies and health care research. The ultimate goal is the prevention, cure and eradication of breast cancer. More information on the research priorities of the CBCRA can be found on their website. Additional Information:
For questions about this initiative and research objectives contact: Dr. Pascale Macgregor For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 5. Canadian HIV Vaccine Initiative. The CIHR Institute of Infection and Immunity is a partner in the Canadian HIV Vaccine Initiative (CHVI). Under this program, applications in the area Discovery and Social Research which are consistent with the guiding principles of CHVI are encouraged. The priorities for basic and social HIV vaccine research were defined at a consultation held in February 2008 and can be found on the CHVI website. These priorities fall under the theme of:
The maximum amount awarded for a single grant is $150,000 per annum for up to three years. CIHR anticipates that up to three grants will be funded through this competition. For questions about this initiative and research objectives contact: Jennifer Ralph For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 6. Ethics. The CIHR Ethics Office will fund applications that are determined to be relevant to the research priorities described below:
This funding opportunity is intended to support excellent applications for 1) research projects in ethics on any relevant research questions within the domains of biomedical sciences, clinical sciences, health services and policy, and population and public health; and 2) conceptual and/or empirical research addressing ethical challenges relevant to CIHR's mandate. A systematic analysis of bioethics or ethics issues associated with health, health care, health research or health policy must be a significant focus of the proposed study. Scientific, social or legal issues, if addressed, should expand the discussion or understanding of bioethical or ethical issues. The maximum amount awarded for a single grant is $50,000 per annum for up to three years. CIHR anticipates that approximately one to three grants will be funded through this competition. The total amount available for this initiative is $450,000 over four fiscal years. This amount may increase if additional funding partners decide to participate. Additional Requirements:
For questions about this initiative and research objectives contact: Lynne Cayer For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 7. HIV/AIDS. The CIHR Institute of Infection and Immunity - HIV/AIDS Research Initiative will fund applications that are determined to be relevant to the research priority areas described below:
(Applicants must select only ONE research priority area.) More information on the research priorities of the HIV/AIDS Research Initiative can be found on the Institute of Infection and Immunity website. Research in the priority areas described above that focuses on at risk populations including people living with HIV/AIDS, men who have sex with men, injection drug users, Aboriginal Peoples, prison inmates, youth at risk, women at risk and people from countries where HIV is endemic, is encouraged. The maximum amount awarded for a single grant is up to $150,000 per annum for up to three years. CIHR anticipates that six grants will be funded through this competition. All applications determined to be relevant to the HIV/AIDS Research Initiative priority areas listed above will be eligible for Bridge Funding. The maximum amount awarded for a single bridge grant is $100,000 per annum for up to one year. Additional Information:
For questions about this initiative and research objectives contact: Jennifer Ralph For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 8. Infrastructure and Operating Grants (Leaders Opportunity Fund). CIHR, in partnership with the Canada Foundation for Innovation (CFI), (2) will fund applications that are determined to be relevant (3) to the research priority area described below:
The objectives of this initiative are: to lessen both applicant and reviewer workload by reducing the number of applications needed to secure both operating and infrastructure support; to create a unique, user-friendly funding tool for researchers and institutions; and to ensure an accurate and fair review of both operating and infrastructure support requests. It is expected that this initiative will allow universities and researchers the opportunity to create streamlined, competitive packages for the funding of infrastructure needs and operational research support. Additional Information:
For questions related to specific CFI competitions and programs, including CFI funding guidelines and how to apply contact: Laurent Messier 9. Musculoskeletal Health, Arthritis, Skin and Oral Health. The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined to be relevant to the strategic research priority areas described on the CIHR-IMHA web site: The maximum amount awarded for a single grant is up to $100,000 per annum for one year. The minimum amount available for this initiative is $400,000. This amount may increase if additional funding partners decide to participate. Additional Information:
For questions about this initiative and research objectives contact: Alita Perry For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 10. Myotonic Dystrophy (Rachel Fund). Muscular Dystrophy Canada and the CIHR Institute of Musculoskeletal Health and Arthiritis (CIHR-IMHA) are pleased to re-launch the "Rachel Fund" to support applications that are determined to be relevant to the research priority area described below:
The Rachel Fund is an initiative to advance research on Myotonic Dystrophy, initiated through a donation provided by Tribute Communities, a generous donor to Muscular Dystrophy Canada. The objective of the Rachel Fund is to support research in one or both of the following research themes:
The Institute of Musculoskeletal Health and Arthritis encourages researchers in disciplines within the Arthritis, Bone, Skin, Muscle, Oral Health and/or Rehabilitation Research communities to develop research in areas covered by IMHA's mandate and its flagship priority, physical activity, mobility and health, as they relate to myotonic dystrophy. Each grant funded through this competition is awarded for a maximum of 3 years. The total amount available for this initiative is $900,000. This amount may increase if additional funding partners decide to participate. Additional Information:
IMHA-Rachel Fund for Myotonic Dystrophy, the Rachel Fund at Muscular Dystrophy Canada and the research priorities of CIHR-IMHA can be found on their websites. For questions about this initiative and research objectives contact: Alita Perry For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 11. Neuromuscular Research (Neuromuscular Research Partnership Program). The CIHR Institute of Genetics, the CIHR Institute of Musculoskeletal Health and Arthritis, the CIHR Institute of Neurosciences, Mental Health and Addiction in partnership with the Amyotrophic Lateral Sclerosis Society of Canada and Muscular Dystrophy Canada will fund applications that are determined to be relevant (5) to the research priority areas described below:
The following broad categories of research are eligible for funding:
Equipment may not be funded under this partnership. The decision will be made in alignment with the open competition decisions. The duration of projects can be for up to (5) years for applications rated above CIHR's funding cut-off and up to (3) three years for applications rated below CIHR's funding cut-off but above 3.7. There is no maximum for a single grant per annum. The maximum amount awarded for a single grant will be as recommended by CIHR peer review for up to 3 years. CIHR anticipates that six to twelve grants will be funded through this competition. Total funding available for this program/competition is $1,649,665. Applications receiving a score of less than 3.7 in the open competition will not be considered for funding. Additional Information:
For questions about this initiative and research objectives contact: Muscular Dystrophy Canada ALS Society of Canada CIHR-IG CIHR-IMHA CIHR-INMHA For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 12. Obesity – Prevention and Treatment. The CIHR Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD) will fund applications that are determined to be relevant to the research priority area described below: For the purposes of this strategic initiative:
Applicants submitting proposals under the strategic initiative can come from any discipline or area of expertise, and can propose research in any number of areas. Applicants must justify how their application contributes to increasing knowledge to prevent or to treat of obesity. These one-year operating grants afford Principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees The maximum amount awarded is $100,000 per grant for a term of one year and will not include equipment. The total amount available for this initiative is $100,000. This amount may increase if additional funding partners decide to participate. For questions about this initiative and research objectives contact: Paul Bélanger For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 13. Pandemic Preparedness (Bridge Funding). The CIHR Institute of Infection and Immunity (CIHR-III) will offer one year bridge funding for applications that are determined to be relevant to the Pandemic Preparedness Strategic Research Initiative as described below:
The maximum amount awarded for a single grant is $100,000 per annum for up to one year. The minimum amount available for this initiative is $ 100,000. Specific Application Instructions:
For questions about this initiative and research objectives contact: Carol Richardson For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 14. Parkinson (Parkinson Society Canada/CIHR-INMHA Research Grant). The CIHR and the Parkinson Society of Canada (6) will fund applications that are determined to be relevant to the research priority areas described below:
The objectives of this priority announcement are to increase interest in and encourage researchers specifically in the area of psychosocial research in Parkinson's disease (PD). Emphasis is placed on research directed towards closing the gap in understanding and treating non-motor symptoms of Parkinson's and may involve qualitative and/or quantitative methodologies. The inclusion of the end user in some component of the research program is a requirement for consideration of the project and must be specified. The following psychosocial research topics have been identified as priority issues by Parkinson Society Canada:
Areas of interest in psychosocial research include but are not limited to:
This grant may be awarded to an individual researcher; however, submissions from teams of researchers that reflect multi-disciplinary approaches and /or inter-regional collaboration are also strongly encouraged. Applications receiving a rating of less than 3.5 will not be considered for funding. More information on the research priorities of Parkinson Society of Canada can be found on their website. The maximum amount awarded for a single grant is up to $50,000 per annum for two years. The total funding available for this competition is $ 100,000. Additional Information:
For questions about the objectives and relevant research areas: Ivy Lim-Carter For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 15. Regional Partnerships Program - Manitoba (RPP-Man). CIHR, through the Regional Partnerships Program (RPP), in partnership with Manitoba Health Research Council may fund applications in Manitoba in all four themes of research, subject to funding availability. The maximum amount awarded for a single grant is $100,000 per year for up to 2 years except where $100,000 is not equivalent to 75% or greater of the approved annual budget of an individual grant, then 75% pro-rated budget amount will apply. The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available. Please note researchers must submit their applications at least two weeks prior to the CIHR deadline to have their applications vetted by the internal review procedures at MHRC in order for their grant to be eligible for consideration for RPP funding. Additional Information:
When applying through ResearchNet, please ensure to select RPP-Manitoba in the drop-down menu of the priority announcement. For additional information on eligibility criteria and funding details, please contact: Shannon Rogalski For questions about this initiative and research objectives contact: Erik Blache For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 16. Regional Partnerships Program - New Brunswick (RPP-NB). CIHR, through the Regional Partnerships Program (RPP), in partnership with New Brunswick-RPP may fund applications in all four themes of health research that contribute to the goal of building health research capacity in New Brunswick, which meet RPP eligibility requirements. More information on the research priorities of New Brunswick can be found on their website. The maximum amount awarded for a single grant is $100,000 per annum for up to 5 years. The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available. Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures of the New Brunswick RPP Advisory Board a minimum of two weeks prior to submitting their application to CIHR in order for their grant to be eligible for consideration for RPP funding. Additional Information:
For eligibility guidelines, see the New Brunswick - CIHR RPP program description. When applying through ResearchNet, please ensure to select RPP-New Brunswick in the drop-down menu of the priority announcement. For questions about the NB RPP Advisory Board review process and criteria, please contact: John Boyne For questions about this initiative and research objectives contact:
Erik Blache For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 17. Regional Partnerships Program - Newfoundland and Labrador (RPP-NL). CIHR, through the Regional Partnerships Program (RPP), in partnership with Newfoundland and Labrador-RPP may fund applications in all four themes of health research in NL which meet RPP eligibility requirements. More information on the research priorities of Newfoundland and Labrador (PDF) can be found on their website. The maximum amount awarded for a single grant will normally be up to $150,000 per annum for up to three years for new grants, and one year for renewals. The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available. Please note researchers must submit their applications at least one month prior to the CIHR application deadline to have their applications vetted by the internal review procedures at RPP-NL in order for their grant to be eligible for consideration for RPP funding. Contact for this process is: Office of Research and Graduate Studies Additional Information:
When applying through ResearchNet, please ensure to select RPP-Newfoundland and Labrador in the drop-down menu of the priority announcement. For questions about this initiative and research objectives contact:
Erik Blache For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 18. Regional Partnerships Program - Nova Scotia (RPP-NS). CIHR, through the Regional Partnerships Program (RPP), in partnership with the Nova Scotia Health Research Foundation may fund (pending budget availability) applications related to any of the four Nova Scotia health research categories which meet RPP requirements. New grants are awarded for up to three years. The maximum amount awarded for a renewal grant is $70,000 for one year. The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available. Please note that in order to be considered for RPP funding, researchers must submit their applications to NSHRF within 10 business days of the CIHR application deadline in order for their grant to be eligible for consideration for RPP funding. Please refer to the 2008/09 Nova Scotia - CIHR RPP Program Requirements document for eligibility criteria, application process and funding details. See under D) Other Health Research Opportunities. When applying through ResearchNet, please ensure to select RPP-Nova Scotia in the drop-down menu of the priority announcement. Contact for this program is: Jennifer McNutt For questions about this initiative and research objectives contact: Erik Blache For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 19. Regional Partnerships Program - Prince Edward Island (RPP-PEI). CIHR, through the Regional Partnerships Program (RPP), in partnership with Prince Edward Island-RPP may fund applications that span the four themes of research that contribute to the goal of building health research capacity in PEI. The following areas of research strength at UPEI reflect these four themes:
More information on the research priorities of Prince Edward Island can be found in the University of Prince Edward Island Strategic Plan. The maximum amount awarded for a single grant is up to $100,000 per annum for up to 3 years. However, the amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available. Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures at the PEI Health Research Institute a minimum of two months prior to submitting their application to CIHR in order for their grant to be eligible for consideration for RPP funding. Additional Information:
For eligibility guidelines, see the PEI - CIHR RPP program description. When applying through ResearchNet, please ensure to select RPP-Prince Edward Island in the drop-down menu of the priority announcement. Please contact the following for additional information: Leslie Cudmore For questions about this initiative and research objectives contact: Erik Blache For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 20. Regional Partnerships Program - Saskatchewan (RPP-SK). CIHR, through the Regional Partnerships Program (RPP), in partnership with Saskatchewan-RPP may fund highly rated applications in Saskatchewan, subject to funding availability. Operating grants from all four themes of research will be supported based upon the ratings that they received. However, half of the available funding will be awarded based upon the following listed research priority areas:
More information on Saskatchewan's research priorities can be found in the Health Research Strategy (PDF). The grant amount will be as recommended by CIHR; the duration will be for two years, unless a shorter period is recommended by CIHR. The amount available to any particular competition will be determined by the number of successful applicants and the amount of funding available. Please note that researchers must have their CIHR applications vetted by the internal review procedures at their University or institution prior to submitting to CIHR in order for their grant to be eligible for consideration for RPP funding:
Please contact the Research Offices at the University of Saskatchewan and the University of Regina for more information: Research Services Office of Research Services To be considered for the Saskatchewan priority areas (see above) researchers must provide a copy of the summary page of their application and a one-page statement justifying the fit of the application with at least one priority area. Researchers will be contacted by the Office of the Associate Vice-President Research (Health) shortly after the application deadline to provide this information. Additional Information:
When applying through ResearchNet, please ensure to select RPP-Saskatchewan in the drop-down menu of the priority announcement. For questions about this initiative and research objectives contact: Erik Blache For questions about, CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. 21. Reproductive and Child Health (Start-Up Grants for New Investigators). The CIHR Institute of Human Development, Child and Youth Health (CIHR-IHDCYH) will fund applications that are determined to be relevant to the research priority areas, as indicated below: The objective of this priority announcement is to further strengthen research that relates to the Strategic Research Priorities of the CIHR-IHDCYH by increasing research capacity. It is expected that this targeted investment will lead to increased success rates for new Principal Investigators in future CIHR regular open competitions. The maximum amount awarded for a single grant is up to $100,000 per annum for up to 1 year. The total amount available for this initiative is $200,000. This amount may increase if additional funding partners decide to participate. Additional Information:
For questions about the objectives and relevant research areas: For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
Research projects may focus on any relevant research question within biomedical, clinical, or health policy research. Examples of relevant questions include defining the scope of TRALI, mechanisms of induction of TRALI in both animals models and patient populations, identification of pathogenic antibodies, identification of best testing methods, studies to inform donor deferral policy making, identification of factors (including genetic factors) that increase a recipient's susceptibility to TRALI, and epidemiology studies to establish the incidence of TRALI. More information on the research priorities of CIHR-ICRH and the Canadian Blood Services (CBS) can be found on their websites. The maximum amount awarded for a single grant is up to $100,000 per annum for up to three years. The total amount available for this initiative is $500,000. This amount may increase if additional funding partners decide to participate. Additional Information:
For questions about this initiative and research objectives contact: Katherine Gardner For questions on CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section. B. Research Related to CIHR Institute Mandates: The following CIHR Institutes are offering priority announcements for research related to their mandates. 23. CIHR Institute of Cancer Research (CIHR-ICR) (Bridge Funding). The objective of the CIHR Institute of Cancer Research One-Year Bridging Operating Grants is to ensure the establishment or the maintenance of excellent research programs. These one-year operating grants give new principal investigators the possibility to strengthen their proposals before resubmitting them, and they afford established principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees.
Additional Information:
For questions about this initiative and the mandate of CIHR-ICR contact: Benoît Lussier 24. CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH) (Bridge Funding).
For questions about this initiative and the mandate of CIHR-ICRH contact: Katherine Gardner 25. CIHR Institute of Gender and Health (CIHR-IGH) (Bridge Funding). The objective of the CIHR Institute of Gender and Health Bridging Operating Grants is to ensure the maintenance of excellent research programs aligned with the mandate of CIHR-IGH. These one-year operating grants afford principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees. The maximum amount awarded will be $100,000 per grant for a term of one year and will not include equipment. Applications receiving a rating of less than 3.8 will not be considered for funding. The total amount available for this competition is $300,000. Additional Information:
For questions about this initiative and the mandate of CIHR-IGH contact: Louise Robert 26. CIHR Institute of Genetics (CIHR-IG) (Bridge Funding: Primary and Secondary Suggested CIHR Institute). The CIHR Institute of Genetics Bridging Operating (One-Year) Grant Program is designed to fund highly ranked operating grant applications relevant to CIHR-IG's mandate that have just missed the CIHR Operating Grants competition funding cut-off. These one-year operating grants afford Principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees. The maximum amount awarded for a single grant is up to $100,000 per annum for up to one year. The total amount currently available for this competition is $300,000. This amount may increase should additional funds become available during the competition. Specific Eligibility Requirements:
For questions about this initiative and the mandate of CIHR-IG contact: Jennifer Ahlgren 27. CIHR Institute of Genetics Maud Menten New Principal Investigator Prizes (2009). The CIHR Institute of Genetics (IG) has established the Maud Menten New Principal Investigator Prize. Dr. Menten's outstanding career as a biomedical scientist led to many achievements including important co-discoveries relating to blood sugar, haemoglobin and kidney functions. In 1913, a collaboration with Leonor Michaelis on the behaviour of enzymes resulted in the Michaelis-Menten equation, a biochemical concept so fundamental that it is familiar to first-year science students. This program is designed to recognize and support the research excellence of Canadian New Investigators working within the IG's mandate. The research grant is intended to offset the direct costs of the recipient's research program.
Specific Eligibility Requirements:
The New Principal Investigator with the highest ranked CIHR Operating Grant application - from the combined results of the September 2008 and March 2009 CIHR Operating Grants competitions - in each research area will be the recipient of one of the three prizes. For each research area, two finalist prizes are also available and will be selected in rank order. For questions about this initiative and the mandate of CIHR-IG contact: Jennifer Ahlgren 28. CIHR Institute of Health Services and Policy Research (CIHR-IHSPR) (Bridge Funding). The objective of the Institute of Health Services and Policy Research (IHSPR) Bridge Funding Operating Grant is to ensure the maintenance of excellent research programs related to IHSPR's mandate area of Health Services and Policy Research. These operating grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees.
For questions about this initiative and the mandate of CIHR-IHSPR contact: Krissy Davidge 29. CIHR Institute of Infection and Immunity (CIHR-III) (Bridge Funding). The maximum amount awarded for a single grant is up to $ 100,000 per annum for up to 1 year. The minimum amount available for this initiative is $ 400,000. For questions about this initiative and the mandate of CIHR-III contact: Bruce Moor 30. CIHR Institute of Neuroscience, Mental Health and Addiction (CIHR-INMHA) (Bridge Funding).
For questions about this initiative and the mandate of CIHR-INMHA contact: Richard Brière 31. CIHR Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD) (Bridge Funding). The objective of the CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) Bridging Operating Grants is to ensure the maintenance of excellent research programs aligned with the mandate of INMD. These one-year operating grants afford Principal Investigators an opportunity to resubmit their research proposal without the loss of momentum, staff, or trainees. The maximum amount awarded is $100,000 per grant for a term of one year and will not include equipment. The total amount available for this initiative is $100,000. This amount may increase if additional funding partners decide to participate. For questions about this initiative and the mandate of CIHR-INMD contact: Paul Bélanger Top Eligibility
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions. Eligibility requirements specific to the Operating Grant Program include the following:
Top Guidelines
Applications funded through the Operating Grant Program are subject to funding policies outlined in the CIHR Grants and Awards Guide. Guidelines governing CIHR's grant programs are outlined in Section 3: General Guidelines for Grant Programs. Applicants are encouraged to demonstrate the use of Gender and Sex-Based Analysis in applications. Allowable Costs Applicants should review the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Financial Administration Guide for a complete listing and description of allowable costs and activities. The full application must provide a detailed justification of all costs. Conditions of Funding All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through the Operating Grant Program. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official Languages Policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR's Support. Successful applicants will be informed of any special financial requirements prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document. Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA) All personal information collected by CIHR about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review. CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this funding opportunity and all matters pertaining thereto. While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the Funding opportunity will be collected, used and disclosed in compliance with the PIPEDA. CIHR Guidelines for Health Research Involving Aboriginal People The CIHR Guidelines for Health Research Involving Aboriginal People came into effect as policy for CIHR-funded research on July 1, 2008. Applicants whose proposed research will involve Aboriginal People are strongly encouraged to familiarise themselves with these guidelines and in particular with the section "Application of the Guidelines," which outlines the situations in which these guidelines apply. Policy on Access to Research Outputs CIHR believes that greater access to research publications and data will promote the ability of researchers and knowledge users in Canada and abroad to use and build on the knowledge needed to address significant health challenges. Open access will promote accessibility to CIHR-funded research and will serve to increase the international visibility of Canadian research. As of January 1, 2008, CIHR grant recipients are reminded to adhere with the responsibilities outlined in the Policy on Access to Research Outputs. Under this policy, grant recipients must make every effort to ensure that research papers and bio-molecular data generated from CIHR funding are freely accessible online. Communication Requirements Grant recipients are required to acknowledge CIHR, its institutes and partners in any communication or publication related to the project. See CIHR General Grants and Awards Policies, Public Communication and Acknowledgement of CIHR's Support for details on CIHR's communication requirements. The contributing institutes/partners will be identified on the Authorization for Funding and decision letter. Top Performance Measurement
CIHR is committed to demonstrating results to Canadians for the money invested in health research. Therefore, processes for monitoring progress and appropriate use of funds, as well as for performance measurement and program evaluation are in place. As a result, funding recipients must:
Top Review Process and Evaluation
Relevance Review A. CIHR Research Priority Areas: CIHR and partner organizations will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described under "CIHR Research Priority Areas" within the "Objectives" section. Relevance of the applications to the research priorities will be determined in the following manner. Prior to peer review, CIHR and the partner organizations will review applications to determine the relevance, or alignment, of the research proposed to the research priority area(s) described above. To conduct relevance review, these representatives will have access to a completed relevance form in addition to anonymized project titles and summaries, provided that applicants have consented to the sharing of information in consideration for other funding opportunities as well as to the sharing of information to observers in completing their ResearchNet application. Upon completion of peer review, the CIHR and the partner organizations will receive the ratings, rankings and peer review committee recommendations on funding level and grant or award term for those applications that 1) are found to be relevant to the specific objectives of the research initiative and the research priority areas described under "CIHR Research Priority Areas"; and 2) are rated within the CIHR fundable range but are not funded through the regular CIHR competition to which they were submitted. These applications will be funded from the top down in order of ranking as far as budgets will allow. Applications that receive a ranking below 3.5 will not be funded. Peer review committees will not be informed of applications submitted for funding through this announcement. B. Research Related to CIHR Institute Mandates: Upon completion of peer review, representatives of each CIHR Institute will receive a randomized list of applications for which the Institute was selected as primary (and where indicated, secondary) Institute under "Suggested Institutes" on the "Project Descriptors" page of the ResearchNet application. The randomized list will include anonymized titles, project summaries and peer review committee recommendations on funding levels. Eligible applications will be funded from the top down in order of ranking as far as budgets will allow. Applications that receive a rating below 3.5 will not be funded. Peer review committees will not be informed of applications submitted for funding through this announcement. Peer Review A CIHR peer review committee will evaluate the full applications. Committee members are selected following CIHR's Policy on Conflict of Interest and Confidentiality in the context of Merit, Relevance and Peer Review (CCIP). For information on CIHR's peer review process in general, see the Peer Review section of CIHR's website. Evaluation Criteria Peer review will be conducted in accordance with The CIHR Peer Review Process - Policies and Responsibilities of Grants Committee Members, including the standard evaluation criteria described under "Factors in the Assessment" (section 6.2). Applications to the CIHR Operating Grant Program are reviewed by one of approximately 50 peer review committees specifically constituted to support the CIHR Operating Grant Program. Each committee consists of about 10-16 members, including a Chairperson and Scientific Officer. For a list of these committees and their respective mandates, refer to Peer Review Committees and Mandates on the CIHR website. Top How to Apply
Note: This funding opportunity requires the use of ResearchNet to apply for funding.
Additional instructions that must be followed for this funding opportunity. A. CIHR Research Priority Areas:
B. Research Related to CIHR Institute Mandates:
Top Contact Information
For questions on CIHR funding guidelines, how to apply, and the peer review process contact: CIHR Info Desk Service Specific information about the Operating Grant Program peer review committees can also be obtained by contacting the individuals listed on the CIHR Committees and Programs Contacts page of the CIHR website. If you are experiencing technical difficulties with your ResearchNet account or the e-Submission process contact: CIHR ResearchNet Support Top Partner/Collaborator Description
N/A Top Additional Information
Top |
| Search Again | Print Preview | Notify a Colleague |
| Support |
 For technical problems, please contact us at 613-941-9080 or by e-mail at support@researchnet-recherchenet.ca, Monday-Friday from 8:30 a.m. to 4:30 p.m. Eastern Time. |
| Important Notices | © 2004-2007 CIHR-IRSC |